considering only the clinically relevant endpoints death , pulmonary embolism and arterial embolism , and with the aim of preventing all three , the only established prophylaxis for thromboembolism during the hospital phase of myocardial infarction , in non-rheumatic atrial fibrillation and in dilated cardiomyopathy , is full dose conventional anticoagulation with either heparin and/or oral anticoagulants .
C0034065
pulmonary embolism
C0019134
heparin